BENEFITING: Dana-Farber Cancer Institute, Inc.
May is Brain Cancer Awareness Month, though the frequency of brain cancer is not as high as other cancers, beauty is nothing without a brain. Brain cancer research only receives a small portion of funding from the National Institute of Health (NIH). With the increasing prevalence of brain cancer in the United States, we need to raise funds to support research that is devoted to finding a cure!
Last June, the most important person in my life was diagnosed with Glioblastoma Multiforme, Grade 4. The initial diagnosis was delivered with minimal hope, for there is no cure for this form of cancer. Glioblastoma is an aggressive and fast-growing, central nervous system tumor that forms from supportive tissue of the brain and spinal cord and is a very common form of brain cancer. For adults with more aggressive glioblastoma, treated with concurrent chemotherapy and radiation therapy, median survival is about 14.6 months and two-year survival is 30%. Familial incidences are not a known risk factor and there is no inheritance pattern. This type of cancer does not discriminate, it affects all ages, all sexes, and all races.
After receiving almost a year of exceptional care from Dr. David Reardon and his wonderful team, he has decided he would like to give back to their highly regarded institution. This fundraiser is dedicating 100% of all proceeds to the Center for Neuro-Oncology at Dana-Farber Cancer Institute in Boston, MA. Currently Dr. Reardon's laboratory is collaborating with immunologists to develop immune-based therapies for cancers of the central nervous system. His combinational therapies have had extraordinary success where 75% of their murine GBM-line are alive, healthy, and without any evidence of new tumor formation or adverse side effect. His research team will be presenting their results at the American Society of Clinical Oncology meeting in Chicago in early June.
Please help us fund the cure! Every contribution counts.